Newbridge, United Kingdom

John Meadows



Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Wrexham, GB (2006)
  • Newbridge, GB (2007 - 2013)

Company Filing History:


Years Active: 2006-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Meadows: Innovator in Drug Solubilization

Introduction

John Meadows is a notable inventor based in Newbridge, GB, recognized for his contributions to the field of drug solubilization. With a total of 3 patents, he has made significant advancements in formulating drugs that are difficult to solubilize in water, particularly those that cause discomfort upon injection.

Latest Patents

One of his latest patents is titled "Synergistic mixed poloxamer systems for the solubilisation of drugs." This innovation addresses the challenge of formulating drugs that are typically painful to inject by utilizing synergistic, aqueous micellar preparations of poloxamers. These preparations allow for the effective administration of such drugs with substantially less pain and can often be prepared with fewer or no co-solvents. Another significant patent is focused on "Anesthetic formulations," specifically highlighting the stability of Propofol when solubilized in aqueous micellar preparations of poloxamers. This formulation proves to be an effective administration form for Propofol, even at low concentrations.

Career Highlights

Throughout his career, John Meadows has worked with reputable companies such as Maelor Pharmaceuticals Limited and Isis Pharmaceuticals, Inc. His work in these organizations has contributed to the development of innovative solutions in the pharmaceutical industry.

Collaborations

John has collaborated with notable individuals in his field, including Mark Geoffrey Rippon and Colum Martin Dwyer. These partnerships have further enhanced his research and development efforts.

Conclusion

John Meadows stands out as an influential inventor in the realm of drug solubilization, with a focus on improving patient comfort during drug administration. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…